HNRNPA2B1 and atherosclerosis: To further stress the relevance of hnRNPA2B1 decrease in protecting against atherosclerosis-related affections, Zhang et al. proved that lncRNA AC105942.1 suppresses SMC pathological proliferation by downregulating hnRNPA2B1 and suggested the latter as a target for novel therapeutic attempts [162,166].